Significant Investments in Biotech and Semiconductors Boost Incheon’s Economic Zone
The Incheon Free Economic Zone Authority (IFEZ) announced on Oct. 12 that it has achieved $553.5 million in foreign direct investment (FDI) declarations for the third quarter of 2025.
This fulfills 92.3% of this year’s target ($600 million), with quarterly declaration amounts recorded at $309.61 million for the first quarter and $184.09 million for the second quarter.
Notably, significant progress was made in core strategic industries such as biotech and semiconductors. In the first half of the year, investment declarations were completed by Sartorius Korea Operations ($250 million), Lotte Biologics ($28.7 million), TOK Advanced Materials ($24.6 million), Orsted ($119.6 million), and Costco Cheongna ($61.4 million). The third quarter saw an additional investment from Starfield Cheongna ($52.5 million).
The FDI arrival amount reached $391.2 million, exceeding the target of $350 million and surpassing last year’s figure by 2.8 times. Consequently, IFEZ’s cumulative FDI declaration amount has reached $16.72 billion.
IFEZ Commissioner Yun Won-sok stated, “Despite uncertainties in domestic and international economies and tariff risks, IFEZ’s proactive IR activities and expansion of foreign resident infrastructure have led to these achievements.”
IFEZ maintains its goals of $600 million in FDI declarations and $350 million in arrivals for this year, actively pursuing investments in sectors such as medical and biotech, advanced strategic industries, and tourism and cultural content industries.
Yun added, “In my second year as head, we expect to exceed the FDI declaration target of $600 million again this year, following last year’s success. We anticipate visible results from new large-scale investment projects in biotech and semiconductor fields, as well as the Kessler Group’s Asian Hollywood investment project, which is being pursued as part of the K-Con Land project.”